Abstract
Purpose. The role of fine lactose in the dispersion of salmeterol xina- foate (SX) from lactose mixtures was studied by modifying the fine lactose concentration on the surface of the lactose carriers using wet decantation.
Methods. Fine lactose was removed from lactose carriers by wet decantation using ethanol saturated with lactose. Particle sizing was achieved by laser diffraction. Fine particle fractions (FPFs) were determined by Twin Stage Impinger using a 2.5% SX mixture, and SX was analyzed by a validated high-performance liquid chromatography method. Adhesion forces between probes of SX and silica and the lactose surfaces were determined by atomic force microscopy.
Results. FPFs of SX were related to fine lactose concentration in the mixture for inhalation grade lactose samples. Reductions in FPF (2- tp 4-fold) of Aeroflo 95 and 65 were observed after removing fine lactose by wet decantation; FPFs reverted to original values after addition of micronized lactose to decanted mixtures. FPFs of SX of sieved and decanted fractions of Aeroflo carriers were significantly different (p < 0.001). The relationship between FPF and fine lactose concentration was linear. Decanted lactose demonstrated surface modification through increased SX-lactose adhesion forces; however, any surface modification other than removal of fine lactose only slightly influenced FPF.
Conclusions. Fine lactose played a key and dominating role in controlling FPF. SX to fine lactose ratios influenced dispersion of SX with maximum dispersion occurring as the ratio approached unity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
H. Steckel and B. W. Mueller. In vitro evaluation of dry powder inhalers I: drug deposition of commonly used devices. Int. J. Pharm. 154:19-29 (1997).
D. Ganderton and N.M, Kassem. Dry powder inhalers. In D. Ganderton and T. Jones (eds.), Advances in Pharmaceutical Sciences, Vol 6. Academic Press, London, 1992 pp. 165-191.
X. M. Zeng, G. P. Martin, C. Marriott, and J. Pritchard. The influence of carrier morphology on drug delivery by dry powder inhalers. Int. J. Pharm. 200:93-106 (2000).
D. Ganderton. The generation of respirable clouds from coarse powder aggregate. J. Biopharm. Sci. 3:101-105 (1992).
J. H. Bell, P. S. Hartley, and J. S. G. Cox. Dry powder aerosols I: a new powder inhalation device. J. Pharm. Sci. 60:1559-1564 (1971).
N. M. Kassem, K. K. L. Ho, and D. Ganderton. The effect of air flow and carrier size on the characteristics of an inspirable cloud. J. Pharm. Pharmacol. 41:14P(1989).
L. Hassan, X. M. Zeng, G. P. Martin, C. Marriott, and J. Prichard. The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate. Int. J. Pharm. 191:1-14 (1999).
H. Steckel and B. W. Muller. In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. Int. J. Pharm. 154:31-37 (1997).
M. Karhu, J. Kuikka, T. Kauppinen, K. Bergstrom, and M. Vidgren. Pulmonary deposition of lactose carriers used in inhalation powders. Int. J. Pharm. 196:95-103 (2000).
Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int. J. Pharm. 172:179-188 (1998a).
J. Broadhed, R. S. K. Edmond, and C. T. Rhodes. The deposition of spray-dried β-galactosidase from dry powder inhaler devices. Drug Dev. Ind. Pharm. 22:813-822 (1996).
S. K. Tee, C. Marriot, X. M. Zeng, and G. P. Martin. The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate. Int. J. Pharm. 208:111-123 (2000).
Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi. A new powder design method to improve inhalation efficiency of pranlukast hydrate dry powder aerosols by surface modification with hydroxypropylmethylcellulose pthalate nanospheres. Pharm. Res. 15:1748-1752 (1998).
L. A. Mackin, G. Rowley, and E. J. Fletcher. An investigation of carrier particle type, electrostatic charge and relative humidity on in-vitro drug deposition from dry powder inhaler formulations. Pharm. Sci. 3:583-586 (1997).
X. M. Zeng, G. P. Martin, S. K. Tee, and C. Marriot. The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in the air stream in vitro. Int. J. Pharm. 176:99-110 (1998).
X. M. Zeng, K. H. Pandhal, and G. P. Martin. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropropionate from dry powder aerosols. Int. J. Pharm. 197:41-52 (2000).
M. D. Louey and P. J. Stewart. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm. Res. 19:1524-1531 (2002).
X. M. Zeng, G. P. Martin, S. K. Tee, A. A. Ghoush, and C. Marriot. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from the dry powder formulation. Int. J. Pharm. 182:133-144 (1999).
M. D. Louey, S. Razia, and P. J. Stewart. Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int. J. Pharm. 252:87-98 (2003).
K. Iida, H. Leuenberger, L. M. Fueng, M. W. Rudi, H. Okamoto, and K. Danzo. Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS). Yakugaku Zasshi 120:113-119 (2000).
P. Lucas, K. Anderson, and J. N. Staniforth. Protein deposition from dry powder inhalers: Fine particle multiplets as performance modifiers. Pharm. Res. 15:562-569 (1998).
F. Podczeck. The influence of particle size distribution and surface roughness of carrier particles on the in vitro properties of dry powder inhalations. Aerosol Sci. and Technol. 31:301-321 (1999).
P. M. Young, D. Cocconi, P. Collombo, R. Bettini, R. Price, D. F. Steele, and M. J. Tobyn. Characterization of a surface modified dry powder inhalation carrier prepared by particle smoothing. J. Pharm. Pharmacol. 54:1339-1344 (2002).
D. Ganderton, D. A. V. Morton, and P. Lucas. Pharmaceutical powders comprising particles of an amino acid. PCT Int. Appl. 45, (2000).
R. Musa, R. Bilzi, P. Ventura, and P. Chiesi. Modified carrier particles for use in dry powder inhalers. PCT Int. Appl. 25(2000).
X. M. Zeng, S. K. Tee, G. P. Martin, and C. Marriot. Effect of mixing procedure and particle size distribution of carrier particles on the deposition of salbutamol sulphate from dry powder inhaler formulations. Proc. Drug Deliv. Lung 7:40-43 (1996).
F. K. Denis, J. R. Clifford, and S. B. S. Philip. Technical note on an improved cyclosizing technique. Proc. Australias Inst. Min. Metall. 251:9-10 (1974).
T. Allen. Powder sampling and particle size measurement. In T. Allen (ed.), Particle Size and Measurement, 5th ed. Chapman and Hall, London, 1997 pp. 216-219.
H. Heywood. Fundamental principles of sub-sieve particle size measurement. Symposium on recent developments in mineral dressing. Inst. Min. Met., London, p. 31(1952).
J. Liu and P. J. Stewart. Deaggregation during the dissolution of benzodiazepines in interactive mixtures. J. Pharm. Sci. 87:1632-1638 (1998).
W. A. Ducker, T. J. Senden, and R. M. Pashley. Direct measurement of colloidal forces using an atomic force microscope. Nature 353:239-241 (1991).
J. P. Cleveland, S. Manne, D. Bocek, and P. K. Hansma. A non destrictive method for determining the spring constant of cantilevers for scanning force microscopy. Rev. Sci. Instrum. 64:403-405 (1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Islam, N., Stewart, P., Larson, I. et al. Lactose Surface Modification by Decantation: Are Drug-Fine Lactose Ratios the Key to Better Dispersion of Salmeterol Xinafoate from Lactose-Interactive Mixtures?. Pharm Res 21, 492–499 (2004). https://doi.org/10.1023/B:PHAM.0000019304.91412.18
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000019304.91412.18